590 related articles for article (PubMed ID: 31115798)
1. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.
Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F
Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798
[TBL] [Abstract][Full Text] [Related]
2. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.
Kim EY; Choi B; Kim JE; Park SO; Kim SM; Chang EJ
Cells; 2020 Jan; 9(1):. PubMed ID: 31935914
[TBL] [Abstract][Full Text] [Related]
4. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
5. Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy.
Cartier A; Leigh T; Liu CH; Hla T
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3157-3166. PubMed ID: 31988136
[TBL] [Abstract][Full Text] [Related]
6. Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR
Xiao S; Yang J
Invest New Drugs; 2019 Feb; 37(1):57-64. PubMed ID: 29860604
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
8. Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation.
Syed SN; Raue R; Weigert A; von Knethen A; Brüne B
Cells; 2019 Jul; 8(8):. PubMed ID: 31357710
[TBL] [Abstract][Full Text] [Related]
9. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.
Palangi A; Shakhssalim N; Parvin M; Bayat S; Allameh A
Clin Transl Oncol; 2019 Sep; 21(9):1240-1249. PubMed ID: 30712233
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.
Gong K; Dong Y; Wang L; Duan Y; Yu J; Sun Y; Bai M; Duan Y
Int J Nanomedicine; 2020; 15():5561-5571. PubMed ID: 32801704
[TBL] [Abstract][Full Text] [Related]
12. S1PR1 signaling in cancer: A current perspective.
Anu B; Namitha NN; Harikumar KB
Adv Protein Chem Struct Biol; 2021; 125():259-274. PubMed ID: 33931142
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
15. S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation.
Song S; Min H; Niu M; Wang L; Wu Y; Zhang B; Chen X; Liang Q; Wen Y; Wang Y; Yi L; Wang H; Gao Q
EBioMedicine; 2018 Nov; 37():168-176. PubMed ID: 30316864
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
[TBL] [Abstract][Full Text] [Related]
17. Targeting sphingosine-1-phosphate signaling for cancer therapy.
Xie Z; Liu H; Geng M
Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway.
Wang H; Huang H; Ding SF
Cell Biol Int; 2018 Nov; 42(11):1492-1502. PubMed ID: 29790626
[TBL] [Abstract][Full Text] [Related]
19. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.
Lee H; Deng J; Kujawski M; Yang C; Liu Y; Herrmann A; Kortylewski M; Horne D; Somlo G; Forman S; Jove R; Yu H
Nat Med; 2010 Dec; 16(12):1421-8. PubMed ID: 21102457
[TBL] [Abstract][Full Text] [Related]
20. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.
Deng J; Liu Y; Lee H; Herrmann A; Zhang W; Zhang C; Shen S; Priceman SJ; Kujawski M; Pal SK; Raubitschek A; Hoon DSB; Forman S; Figlin RA; Liu J; Jove R; Yu H
Cancer Cell; 2012 May; 21(5):642-654. PubMed ID: 22624714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
